ACE and Alzheimer disease: We have analyzed an existing database for ACE mutations and have identified that ~4–5% of the general population may have damaging, loss-of-function (LoF) ACE mutations that may result in very low tissue ACE expression and, therefore, increased risk for the development of late-onset Alzheimer’s disease.